Atypical Adenomatous Hyperplasia

Watchlist
Retrieved
2021-01-18
Source
Trials
Genes
Drugs

Atypical adenomatous hyperplasia is a subtype of pneumocytic hyperplasia in the lung. It can be a precursor lesion of in situ adenocarcinoma of the lung (bronchioloalveolar carcinoma). In prostate tissue biopsy, it can be confused for adenocarcinoma of the prostate. The needle biopsy rate is less than 1%.

Pathology

Morphological differential diagnosis

  • Multifocal micronodular pneumocyte hyperplasia (MMPH)
  • in situ pulmonary adenocarcinoma (bronchioloalveolar carcinoma – BAC)

Variants

  • multiple atypical adenomatous hyperplasia
  • disseminated AAH

Histopathological images

See also

  • EGFR
  • KRAS